Bioaffinity Technologies, Stock Analysis

BioAffinity Stock Analysis Notes

About 30.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.66. Some equities with similar Price to Book (P/B) outperform the market in the long run. bioAffinity Technologies, recorded a loss per share of 0.91. The entity had not issued any dividends in recent years. bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company was founded in 2014 and is based in San Antonio, Texas. Bioaffinity Technologies operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 14 people. For more info on bioAffinity Technologies, please contact the company at 210 698 5334 or go to https://www.bioaffinitytech.com.

bioAffinity Technologies, Investment Alerts

bioAffinity Technologies, Upcoming and Recent Events

BioAffinity Largest EPS Surprises

View All Earnings Estimates

BioAffinity Stock Institutional Investors

Note, although BioAffinity Technologies,'s institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

BioAffinity Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 19.81 M.

BioAffinity Profitablity

The company has Profit Margin (PM) of (1.19) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.87) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.87.

Management Efficiency

bioAffinity Technologies, has return on total asset (ROA) of (0.6978) % which means that it has lost $0.6978 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.5152) %, meaning that it created substantial loss on money invested by shareholders. BioAffinity Technologies,'s management efficiency ratios could be used to measure how well BioAffinity Technologies, manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -1.25. The BioAffinity Technologies,'s current Return On Capital Employed is estimated to increase to -1.46. At this time, BioAffinity Technologies,'s Fixed Asset Turnover is most likely to increase slightly in the upcoming years. The BioAffinity Technologies,'s current Asset Turnover is estimated to increase to 0.29, while Non Currrent Assets Other are projected to decrease to roughly 10 K.

Technical Drivers

As of the 27th of March, BioAffinity Technologies, shows the Risk Adjusted Performance of (0.18), coefficient of variation of (457.61), and Standard Deviation of 7.64. bioAffinity Technologies, technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm bioAffinity Technologies, treynor ratio, as well as the relationship between the value at risk and skewness to decide if bioAffinity Technologies, is priced correctly, providing market reflects its regular price of 0.28 per share. As bioAffinity Technologies, appears to be a penny stock we also recommend to validate its jensen alpha numbers.

bioAffinity Technologies, Price Movement Analysis

bioAffinity Technologies, Insider Trading Activities

BioAffinity Technologies, Predictive Daily Indicators

BioAffinity Technologies, Forecast Models

BioAffinity Technologies,'s time-series forecasting models are one of many BioAffinity Technologies,'s stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary BioAffinity Technologies,'s historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how BioAffinity Technologies, prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling BioAffinity shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as BioAffinity Technologies,. By using and applying BioAffinity Stock analysis, traders can create a robust methodology for identifying BioAffinity entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. BioAffinity analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. BioAffinity analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

bioAffinity Technologies, stock analysis indicators help investors evaluate how BioAffinity Technologies, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading BioAffinity Technologies, shares will generate the highest return on investment. By understating and applying BioAffinity Technologies, stock analysis, traders can identify BioAffinity Technologies, position entry and exit signals to maximize returns.

When running BioAffinity Technologies,'s price analysis, check to measure BioAffinity Technologies,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioAffinity Technologies, is operating at the current time. Most of BioAffinity Technologies,'s value examination focuses on studying past and present price action to predict the probability of BioAffinity Technologies,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioAffinity Technologies,'s price. Additionally, you may evaluate how the addition of BioAffinity Technologies, to your portfolios can decrease your overall portfolio volatility.